Search Results - "Østergaard, Kamilla"
-
1
Extended interval dosing with ocrelizumab in multiple sclerosis
Published in Multiple sclerosis (01-06-2024)“…Background: This study investigates clinical and biomarker differences between standard interval dosing (SID) and extended interval dosing (EID) of ocrelizumab…”
Get full text
Journal Article -
2
Characterization of the TNF and IL-1 systems in human brain and blood after ischemic stroke
Published in Acta neuropathologica communications (05-06-2020)“…Preclinical and clinical proof-of-concept studies have suggested the effectiveness of pharmacological modulation of inflammatory cytokines in ischemic stroke…”
Get full text
Journal Article -
3
Migraine with aura and risk of silent brain infarcts and white matter hyperintensities: an MRI study
Published in Brain (London, England : 1878) (01-07-2016)“…A small number of population-based studies reported an association between migraine with aura and risk of silent brain infarcts and white matter…”
Get full text
Journal Article -
4
Migraine with visual aura associated with thicker visual cortex
Published in Brain (London, England : 1878) (01-03-2018)“…Recent MRI studies of cortical thickness in patients with migraine with aura have yielded conflicting results, possibly due to small numbers of subjects. Gaist…”
Get full text
Journal Article -
5
Persistently reduced humoral and sustained cellular immune response from first to third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients
Published in Multiple sclerosis and related disorders (01-04-2022)“…•Levels of antibodies are sustained after 3rd mRNA vaccination of MS patients on anti-CD20 treatment.•Only one third had detectable levels of antibodies and…”
Get full text
Journal Article -
6
Migraine with aura in women is not associated with structural thalamic abnormalities
Published in NeuroImage clinical (01-01-2020)“…•Abnormal structure of thalamic nuclei has been proposed to be a feature of migraine pathophysiology.•We measured volume of thalamic nuclei in 156 migraine…”
Get full text
Journal Article -
7
Long-term use of antiplatelet drugs by patients with transient ischaemic attack
Published in European journal of clinical pharmacology (01-02-2014)“…Purpose To determine the degree of long-term non-persistence to antiplatelet drugs in patients with transient ischaemic attack (TIA) and identify determinants…”
Get full text
Journal Article -
8
Discontinuation of antiplatelet treatment and risk of recurrent stroke and all-cause death: a cohort study
Published in Neuroepidemiology (01-01-2014)“…We wished to examine the impact of antiplatelet drug discontinuation on recurrent stroke and all-cause mortality. We identified a cohort of incident ischaemic…”
Get more information
Journal Article -
9
Long-term use of antiplatelet drugs by stroke patients: a follow-up study based on prescription register data
Published in European journal of clinical pharmacology (01-12-2012)“…Purpose Treatment with antiplatelet drugs is a key element of secondary stroke prevention. We investigated long-term antiplatelet drug use in stroke patients…”
Get full text
Journal Article -
10
No effect of ablation of surfactant protein-D on acute cerebral infarction in mice
Published in Journal of neuroinflammation (19-07-2014)“…Crosstalk between the immune system in the brain and the periphery may contribute to the long-term outcome both in experimental and clinical stroke. Although,…”
Get full text
Journal Article -
11
Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine doses
Published in Journal of neurology, neurosurgery and psychiatry (01-11-2023)“…BackgroundOur study investigated the rate of breakthrough SARS-CoV-2 infection and clinical outcomes in a cohort of multiple sclerosis (MS) patients who were…”
Get full text
Journal Article -
12
Humoral immune response following SARS-CoV-2 mRNA vaccination concomitant to anti-CD20 therapy in multiple sclerosis
Published in Multiple sclerosis and related disorders (01-11-2021)“…The immunogenicity of COVID-19 vaccine among patients receiving anti-CD20 monoclonal antibody (Ab) treatment has not been fully investigated. Detectable levels…”
Get full text
Journal Article -
13
Reduced humoral immune response after mRNA vaccination correlates with breakthrough SARS-CoV-2 infection in ocrelizumab-treated multiple sclerosis patients (P12-3.005)
Published in Neurology (25-04-2023)“…Abstract only…”
Get full text
Journal Article